Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
Curr Eye Res ; 45(5): 563-575, 2020 05.
Artigo em Inglês | MEDLINE | ID: mdl-31657234

RESUMO

Purpose: To investigate and compare the effect of warm compresses on meibomian gland dysfunction and Demodex folliculorum blepharitis.Methods: Forty-two subjects (13 males, 29 females; mean age of 56.45 years) enrolled and completed the two-month warm compress treatment study. Three warm compress therapies were compared: Warm face cloth, MGDRx EyeBag® and OPTASETM Moist Heat Mask. Subjects attended for four visits: baseline, two weeks, four weeks, and eight weeks. Subjective symptoms, osmolarity, non-invasive tear break-up time, ocular surface staining, Schirmer I test, meibum expressibility and clarity, and eyelash manipulation and epilation to assess for the presence of Demodex folliculorum, were measured at each visit.Results: Meibomian gland dysfunction, based on a composite score of meibum quality and expressibility, reduced significantly with the MGDRx EyeBag® and the OPTASETM Moist Heat Mask (p < .05). There was no significant difference in efficacy for treating meibomian gland dysfunction between the two devices (p = .29). No improvement in meibomian gland dysfunction was detected with the warm face cloth. Only the OPTASETM Moist Heat Mask significantly reduced the quantity of Demodex folliculorum over eight-weeks of treatment (p = .036, only baseline to week eight significant p = .008). Symptoms and ocular surface staining improved significantly in all three groups (p < .05). There was no significant change observed in osmolarity, non-invasive tear break-up time or Schirmer I test within each group (p > .05, respectively).Conclusion: The MGDRx EyeBag® and the OPTASETM Moist Heat Mask exhibited superior efficacy in treating signs and symptoms of meibomian gland dysfunction, compared to the use of a warm face cloth, over the eight-week period. The OPTASETM Moist Heat Mask demonstrated dual therapeutic abilities, treating both meibomian gland dysfunction and Demodex folliculorum blepharitis. Repeated application of heat for the treatment of meibomian gland dysfunction may continue to present a good home-remedy option for patients.


Assuntos
Bandagens , Blefarite/terapia , Infecções Oculares Parasitárias/terapia , Hipotermia Induzida/instrumentação , Disfunção da Glândula Tarsal/terapia , Infestações por Ácaros/terapia , Ácaros , Adulto , Idoso , Animais , Blefarite/parasitologia , Método Duplo-Cego , Síndromes do Olho Seco/fisiopatologia , Infecções Oculares Parasitárias/parasitologia , Pestanas/parasitologia , Feminino , Humanos , Masculino , Disfunção da Glândula Tarsal/fisiopatologia , Pessoa de Meia-Idade , Infestações por Ácaros/parasitologia , Concentração Osmolar , Estudos Prospectivos , Microscopia com Lâmpada de Fenda , Inquéritos e Questionários , Lágrimas/fisiologia , Resultado do Tratamento
2.
Cont Lens Anterior Eye ; 41(1): 77-82, 2018 02.
Artigo em Inglês | MEDLINE | ID: mdl-29074306

RESUMO

PURPOSE: To compare the efficacy of Dr Organic Tea Tree Face Wash, OcuSoft Lids Scrub Plus and the BlephEx™ device at treating of Demodex folliculorum blepharitis. METHODS: Eighty-six subjects (33 males/36 females) were enrolled in a randomised controlled interventional treatment study. Subjects completed a dry eye symptom questionnaire and were assessed for presence of Demodex folliculorum. Subjects were divided into three groups according to treatment: Dr Organic Tea Tree Face Wash (A) (n=28), OcuSoft Lid Scrub Plus (B) (n=30), or in-house lid scrub with the BlephEx™ device before nightly lid scrubs with OcuSoft Lid Scrub Plus (C) (n=28). Subjects were advised to clean their eyelids nightly for four weeks. Each subject was re-assessed for symptoms and Demodex folliculorum blepharitis after two weeks and four weeks of treatment. RESULTS: The quantity of Demodex folliculorum was significantly reduced after four weeks of treatment in all three groups (p<0.05). Overall, there was no difference in efficacy between the three treatments (p>0.1). Symptoms reported by subjects were significantly improved after two and four weeks of treatment (p<0.05). Overall, there was no difference in efficacy between the three treatments to reduce symptoms after two or four weeks (p= 0.813 and p=0.646 respectively). CONCLUSION: All three methods tested have shown good ability to reduce Demodex folliculorum quantity, improve subjective symptoms and help treat Demodex folliculorum blepharitis.


Assuntos
Blefarite/terapia , Infecções Oculares Parasitárias/tratamento farmacológico , Pestanas/parasitologia , Infestações por Ácaros/tratamento farmacológico , Ácaros , Octanóis/farmacologia , Fitoterapia/métodos , Óleo de Melaleuca/uso terapêutico , Animais , Blefarite/diagnóstico , Blefarite/parasitologia , Infecções Oculares Parasitárias/diagnóstico , Infecções Oculares Parasitárias/parasitologia , Feminino , Humanos , Masculino , Infestações por Ácaros/diagnóstico , Infestações por Ácaros/parasitologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA